Anaplasmosis

LINDEN, N.J., Aug. 20, 2024 /PRNewswire/ -- ACCU Reference Medical Laboratory, a leading provider of advanced diagnostic services, is proud to announce the implementation and availability of our new molecular PCR (Polymerase Chain Reaction) panels for the diagnosis of tick-borne diseases. This groundbreaking development promises to enhance the accuracy, speed, and comprehensiveness of diagnosing these diseases, ensuring better patient outcomes. Innovative Tick-Borne Disease Diagnostic Continue Reading A new Molecular PCR Test for Tick-Borne Disease allows providers to quickly find the appropriate treatment. Post this Tick-borne diseases are a growing concern, nationwide, with cases on the rise, due to increasing tick populations and expanding geographic ranges. These diseases, including Lyme Disease, Anaplasmosis, Babesiosis, Ehrlichiosis, and Rickettsia Species can present with non-specific symptoms that complicate diagnosis. Early and accurate detection is crucial for effective treatment and prevention of severe complications. The new molecular PCR panels introduced by ACCU Reference Medical Lab offer a highly sensitive and specific method for detecting various tick-borne pathogens. This cutting-edge technology allows for the simultaneous identification of multiple pathogens in a single test, providing a comprehensive diagnostic solution. Key Benefits of the new PCR panels for diagnostic of tick-borne pathogens Enhanced Sensitivity and Specificity: The molecular PCR panels are designed to detect even low levels of pathogen DNA, ensuring accurate diagnosis even in early stages of infection. Rapid Turnaround Time: Results are available within hours, allowing for prompt clinical decision-making and initiation of appropriate treatment. Comprehensive Detection: The panels cover a broad range of tick-borne pathogens, reducing the need for multiple tests and improving diagnostic efficiency. Minimally Invasive: The tests require only a small blood sample, making the process easier and more comfortable for patients. Expert Commentary "We are thrilled to bring this advanced diagnostic tool to our healthcare providers and patients," said Dr. Julian Arce, Laboratory Director of ACCU Reference Medical Lab. "Our new molecular PCR panels represent a significant leap forward in the fight against tick-borne diseases. By providing faster and more accurate diagnoses, we aim to improve patient outcomes and contribute to public health efforts in managing these complex infections." About ACCU Reference Medical Lab ACCU Reference Medical Lab is a premier multi-specialty reference laboratory dedicated to providing comprehensive diagnostic services, nationwide. With a focus on accuracy, reliability, and innovation, the laboratory offers a wide range of tests to support healthcare providers in delivering optimal patient care. For more information, please visit . SOURCE Accu Reference Medical Lab

BATON ROUGE, La., July 17, 2024 /PRNewswire/ -- With the spread of anaplasmosis reaching unprecedented levels across the United States, University Products continues to be the leading provider of the world's only inactivated Bovine Anaplasmosis vaccine, offering a cost-effective, easy-to-administer, and sustainable solution for a cattle industry under siege. While traditional methods such as pest control and chlortetracycline (CTC) medicines provide some relief, they fall far short of the comprehensive protection needed to protect herds now and in the future. Continue Reading Anaplasma marginale Bovine Anaplasmosis Vaccine "Antibiotics were never meant to be a routine cure, but are an emergency response to breakthrough infections," said Gene Luther from University Products. "Antibiotic overuse can lead to major antibiotic resistance. They're also not cost effective. Vaccination is really the only route that makes sense, both biologically and economically." Why Traditional Methods Are Insufficient to Combat Anaplasmosis Anaplasmosis in cattle is primarily spread through bites from infected ticks and horseflies. The transmission process begins when these parasites feed on an infected animal and acquire the Anaplasma marginale bacteria. The bacteria complete part of their life cycle in each tick's gut before moving to the salivary glands and being transmitted to other animals through repeated bites. Similarly, horseflies can spread the disease for up to two hours after feeding on an infected host. Eliminating these pests is nearly impossible, while battling them has become a never-ending, costly, and mostly futile effort for ranchers. Once infected, the disease continues to spread through blood or contaminated equipment that is improperly cleaned and reused. Symptoms in infected animals appear 3-6 weeks post-infection, ranging from mild anemia, fever, depression, and isolation; while severe infected adults exhibit jaundice and other symptoms, potentially leading to death. Early diagnosis is particularly challenging in young animals, which may only exhibit fever and increased breathing rates due to their faster red blood cell regeneration. This can easily lead to chronic carriers that often do not show signs unless they are immunocompromised, before going on to infect many others before symptoms become apparent. And this is why most treatment regimens improperly focus on treating animals after they have been infected, rather than using vaccination. University Products' Anaplasmosis Vaccine: A Superior Solution University Products' anaplasmosis vaccine offers a straightforward and economical approach to disease mitigation for multiple reasons: Cost-Effective: The vaccine is significantly less expensive than the cumulative costs of CTC feed and ongoing pest control efforts. Testing animals for anaplasmosis and subsequently culling or separating infected animals adds further financial strain to ranchers, making vaccination a more budget-friendly option. Ease of Use: With just two doses in the first year, followed by an annual booster, the vaccine simplifies the mitigation process. Producers can eliminate the guesswork and labor associated with ensuring cattle consume adequate medicated feed. Reliable Protection: Unlike CTC feed, which may not provide consistent protection, the vaccine offers great protection against the loss of animals due to anaplasmosis, reducing the risk of antibiotic resistance and ensuring healthier herds. "Our vaccine has always been a game-changer – we've got 25 years of experience to prove it," said Gene Luther. "And a simple vaccination allows producers to focus on other critical aspects of their operations, without the constant worry of pest control and medicated feed." A detailed description of the vaccine and its method of administration is publicly available for PDF download. For more information on vaccine availability for ranchers and veterinarians, please contact University Products directly. About University Products LLC Based in Louisiana, University Products specializes in approved (for experimental use) bovine vaccines. Their anaplasmosis vaccine minimizes clinical signs in at-risk animals, is safe during pregnancy, and requires two initial doses plus annual boosters. The company is also researching vaccines for bovine babesiosis and theileriosis. Veterinarians can inquire about availability by emailing directly at [email protected]. Media Contact: Gene Luther, Director 1-225-334-0851 [email protected] SOURCE University Products LLC

BATON ROUGE, La., Feb. 22, 2024 /PRNewswire/ -- With the annual vector season coming up, University Products recently underscored the critical importance of early vaccination against bovine anaplasmosis to reduce herd losses. Offering a sensible and budget-friendly solution for cattle farmers nationwide, the University Products Anaplasmosis Vaccine has been field-tested for over 20 years and provides superior protection against this devastating endemic disease. Continue Reading University Products LLC University Products LLC "Anaplasmosis remains a longstanding challenge for the cattle industry," said Gene Luther, Director of University Products. "It significantly impacts the health and productivity of herds every single year and it hits hard in the spring, summer and fall especially, when insects like ticks and biting flies begin to flourish, spreading disease. So you don't want to wait until your herd is already infected before you start thinking about preventive measures. Start now. Especially since the FDA has imposed stricter rules for antibiotic use." University Products' vaccine stands out for its affordability, with per-dose costs nearly half that of diagnostic lab testing, and also for its effectiveness in reducing clinical symptoms associated with anaplasmosis. Getting Ahead of Vector Season: Navigating Regulatory Changes The importance of timely and effective disease management strategies is highlighted by recent draft guidance from the Food and Drug Administration concerning antimicrobial drugs given to food -producing animals. Those drugs, previously much easier to get, now require veterinarian approval and administration. The National Cattlemen's Beef Association (NCBA) also weighed in on the potential challenges of implementing new FDA guidelines, which now also require duration labeling for products treating anaplasmosis. NCBA Chief Veterinarian Dr. Kathy Simmons warned that such labeling was problematic at best, stating: "Some of these diseases that are vector borne see variations in the vector season based on the climate that you're raising cattle. They may not be able to give a specific duration. They may have to publish a maximum duration and that won't be easy either." Of this specific concern, Gene Luther from University Products said, "This just underscores the many challenges our industry faces when dealing with bovine disease. But fortunately, our vaccine is already a straightforward, reliable solution. Our vaccine can be used in any climate, during any season." Some General Spring Calving Vector Recommendations: Vaccinate herds for anaplasmosis, if not previously done. Continue other vector measures for the herd like fly and tick control programs. Check spraying equipment, dust bags, and oilers, and obtain needed chemicals or tags for fly and tick control. Consider professional controlled-burns and/or chemical sprays to keep excessive weeds and brush in check. Always contact professionals for these mitigation measures. The Bottom Line: Economic Benefits of Vaccines "Our vaccine's affordability enables more small and mid-sized cattle farmers to protect their herds too," said Gene Luther. "While minimizing financial strain. That's who we try to reach first – who we try to help the most: farmers who do not have enormous corporate budgets to work with. These folks need help that is immediate and cost effective." The University Products vaccine does not prevent infection, but when properly used, significantly reduces clinical signs in at-risk animals. The vaccine requires only two doses in the first year, with one annual booster each year thereafter, and is safe to use in any stage of bovine pregnancy. A detailed description of the vaccine and its method of administration is publicly available for PDF download. For more information on vaccine availability for ranchers and veterinarians, please contact University Products directly. About University Products LLC Based in Louisiana, University Products specializes in USDA approved (for experimental use) bovine vaccines. Their anaplasmosis vaccine minimizes clinical signs in at-risk animals, is safe during pregnancy, and requires two initial doses plus annual boosters. The company is also researching vaccines for bovine babesiosis and theileriosis. Veterinarians can inquire about availability by emailing directly at [email protected]. Certain facts, quotes, and guidelines sourced from: Oklahoma State University: Media Contact: Gene Luther, Director 1-225-334-0851 [email protected] SOURCE University Products LLC